Works by Chung, Choon‐Hee

Results: 54
    1

    Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2743, doi. 10.1111/dom.15164
    By:
    • Park, Hyeong Kyu;
    • Kim, Kyoung‐Ah;
    • Min, Kyung‐Wan;
    • Sohn, Tae‐Seo;
    • Jeong, In Kyung;
    • Ahn, Chul Woo;
    • Kim, Nan‐Hee;
    • Park, Ie Byung;
    • Cho, Ho Chan;
    • Chung, Choon Hee;
    • Choi, Sung Hee;
    • Park, Kang Seo;
    • Yang, Seoung‐Oh;
    • Lee, Kwan Woo
    Publication type:
    Article
    2

    Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1865, doi. 10.1111/dom.15046
    By:
    • Kwak, Soo Heon;
    • Han, Kyung Ah;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Kim, EunSook;
    • Won, Jong Chul;
    • Kang, Jun Goo;
    • Chung, Choon Hee;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Won, Kyu Chang;
    • Kim, Sin Gon;
    • Cho, Seung Ah;
    • Cho, Bo Young;
    • Park, Kyong Soo
    Publication type:
    Article
    3
    4

    Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2408, doi. 10.1111/dom.13394
    By:
    • Han, Kyung‐ah;
    • Chon, Suk;
    • Chung, Choon Hee;
    • Lim, Soo;
    • Lee, Kwan‐woo;
    • Baik, Seihyun;
    • Jung, Chang Hee;
    • Kim, Dong‐sun;
    • Park, Kyong Soo;
    • Yoon, Kun‐ho;
    • Lee, In‐kyu;
    • Cha, Bong‐soo;
    • Sakatani, Taishi;
    • Park, Sumi;
    • Lee, Moon‐kyu
    Publication type:
    Article
    5

    A 52‐week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add‐on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1535, doi. 10.1111/dom.13256
    By:
    • for the Gemigliptin Study 006 Group;
    • Jung, Chan‐Hee;
    • Rhee, Eun‐Jung;
    • Lee, Won‐Young;
    • Min, Kyung Wan;
    • Shivane, Vyankatesh K.;
    • Sosale, Aravind R.;
    • Jang, Hak Chul;
    • Chung, Choon Hee;
    • Nam‐Goong, Il Seong
    Publication type:
    Article
    6
    7
    8

    Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study ( TROICA study)

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 635, doi. 10.1111/dom.12866
    By:
    • Ahn, Chang Ho;
    • Han, Kyung Ah;
    • Yu, Jae Myung;
    • Nam, Joo Young;
    • Ahn, Kyu Jeung;
    • Oh, Tae Keun;
    • Lee, Hyoung Woo;
    • Lee, Dae Ho;
    • Kim, Jaetaek;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Kim, Byung Joon;
    • Park, Seok Won;
    • Park, Hyeong Kyu;
    • Lee, Kwang Jae;
    • Kim, Sang‐Wook;
    • Park, Jeong Hyun;
    • Ko, Kwan Pyo;
    • Kim, Chong Hwa;
    • Lee, Hyunjin
    Publication type:
    Article
    9

    Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model.

    Published in:
    European Journal of Nutrition, 2018, v. 57, n. 2, p. 761, doi. 10.1007/s00394-016-1366-y
    By:
    • Boonloh, Kampeebhorn;
    • Lee, Eun Soo;
    • Kim, Hong Min;
    • Kwon, Mi Hye;
    • Kim, You Mi;
    • Pannangpetch, Patchareewan;
    • Kongyingyoes, Bunkerd;
    • Kukongviriyapan, Upa;
    • Thawornchinsombut, Supawan;
    • Lee, Eun Young;
    • Kukongviriyapan, Veerapol;
    • Chung, Choon Hee
    Publication type:
    Article
    10
    11
    12

    RIPK3 Contributes to Lyso-Gb3-Induced Podocyte Death.

    Published in:
    Cells (2073-4409), 2021, v. 10, n. 2, p. 245, doi. 10.3390/cells10020245
    By:
    • Kim, So-Young;
    • Park, Samel;
    • Lee, Seong-Woo;
    • Lee, Ji-Hye;
    • Lee, Eun Soo;
    • Kim, Miri;
    • Kim, Youngjo;
    • Kang, Jeong Suk;
    • Chung, Choon Hee;
    • Moon, Jong-Seok;
    • Lee, Eun Young;
    • Sayer, John
    Publication type:
    Article
    13
    14

    Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes.

    Published in:
    Journal of Diabetes Investigation, 2015, v. 6, n. 2, p. 219, doi. 10.1111/jdi.12261
    By:
    • Kim, Ji‐Hyun;
    • Ahn, Ji‐Hyun;
    • Kim, Soo‐Kyung;
    • Lee, Dae‐Ho;
    • Kim, Hye‐Soon;
    • Shon, Ho‐Sang;
    • Jeon, Hyun‐Jeong;
    • Kim, Tae‐Hwa;
    • Cho, Yong‐Wook;
    • Kim, Jae‐Taek;
    • Han, Sung‐Min;
    • Chung, Choon‐Hee;
    • Ryu, Ohk‐Hyun;
    • Lee, Jae‐Min;
    • Lee, Soon‐Hee;
    • Kwon, Min‐Jeong;
    • Kim, Tae‐kyun;
    • Namgoong, Il‐Seong;
    • Kim, Eun‐Sook;
    • Jung, In‐Kyung
    Publication type:
    Article
    15

    Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.

    Published in:
    Journal of Diabetes Investigation, 2014, v. 5, n. 6, p. 701, doi. 10.1111/jdi.12201
    By:
    • Kim, Hye‐soon;
    • Kim, Doo‐man;
    • Cha, Bong‐soo;
    • Park, Tae Sun;
    • Kim, Kyoung‐ah;
    • Kim, Dong‐lim;
    • Chung, Choon Hee;
    • Park, Jeong‐hyun;
    • Jang, Hak Chul;
    • Choi, Dong‐seop
    Publication type:
    Article
    16
    17
    18

    Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

    Published in:
    Clinical Endocrinology, 2007, v. 66, n. 2, p. 282, doi. 10.1111/j.1365-2265.2006.02723.x
    By:
    • Kim, Hyeong Jin;
    • Kang, Eun Seok;
    • Kim, Dae Jung;
    • Kim, So Hun;
    • Ahn, Chul Woo;
    • Cha, Bong Soo;
    • Nam, Moonsuk;
    • Chung, Choon Hee;
    • Lee, Kwan Woo;
    • Nam, Chung Mo;
    • Lee, Hyun Chul
    Publication type:
    Article
    19

    Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea.

    Published in:
    Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 1495, doi. 10.2147/DMSO.S334944
    By:
    • Kim, Hye Soon;
    • Yu, Jae Myung;
    • Jang, Hak Chul;
    • Choi, Eui Kwang;
    • Park, Jeong Hyun;
    • Shon, Ho Sang;
    • Chung, Choon Hee;
    • Park, Keun-Gyu;
    • Cho, Jae Hyoung;
    • Kim, Won;
    • Lee, Kyoung Hwa;
    • Lee, Jee Hyun;
    • Yoo, Soon Jib
    Publication type:
    Article
    20
    21
    22
    23

    EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis.

    Published in:
    Experimental & Molecular Medicine EMM, 2024, v. 56, n. 12, p. 2673, doi. 10.1038/s12276-024-01360-6
    By:
    • Son, Seung Seob;
    • Jeong, Hee Seul;
    • Lee, Seong-Woo;
    • Lee, Eun Soo;
    • Lee, Jeong Geon;
    • Lee, Ji-Hye;
    • Yi, Jawoon;
    • Park, Mi Ju;
    • Choi, Min Sun;
    • Lee, Donghyeong;
    • Choi, Sin Young;
    • Ha, Jiheon;
    • Kang, Jeong Suk;
    • Cho, Nam-Jun;
    • Park, Samel;
    • Gil, Hyo-Wook;
    • Chung, Choon Hee;
    • Park, Joon Seok;
    • Kim, Myung Hee;
    • Park, Jihwan
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.

    Published in:
    Diabetes/Metabolism Research & Reviews, 2015, v. 31, n. 3, p. 295, doi. 10.1002/dmrr.2613
    By:
    • Jung, Chang Hee;
    • Park, Cheol‐Young;
    • Ahn, Kyu‐Joeng;
    • Kim, Nan‐Hee;
    • Jang, Hak‐Chul;
    • Lee, Moon‐Kyu;
    • Park, Joong‐Yeol;
    • Chung, Choon‐Hee;
    • Min, Kyung‐Wan;
    • Sung, Yeon‐Ah;
    • Park, Jeong‐Hyun;
    • Kim, Sung Jin;
    • Lee, Hyo Jung;
    • Park, Sung‐Woo
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial 接受基础胰岛素优化治疗之后需要胰岛素强化治疗的患者使用基础-餐时胰岛素治疗与使用预混胰岛素治疗的对照试验:一项为期24周的随机非劣性试验

    Published in:
    Journal of Diabetes, 2016, v. 8, n. 3, p. 405, doi. 10.1111/1753-0407.12312
    By:
    • Jin, Sang ‐ Man;
    • Kim, Jae Hyeon;
    • Min, Kyung Wan;
    • Lee, Ji Hyun;
    • Ahn, Kue Jeong;
    • Park, Jeong Hyun;
    • Jang, Hak Chul;
    • Park, Seok Won;
    • Lee, Kwan Woo;
    • Won, Kyu Chang;
    • Kim, Young ‐ Il;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Lee, Jee ‐ Hyun;
    • Lee, Moon ‐ Kyu
    Publication type:
    Article
    49
    50